You are here:
Publication details
Screening for von Hippel-Lindau disease in patients with CNS hemangioblastomas
Authors | |
---|---|
Year of publication | 2002 |
Type | Article in Proceedings |
Conference | International Journal of Molecular Medicine |
MU Faculty or unit | |
Citation | |
Description | Disclosing a VHL case among those with only a solitary hemangioblastoma requires an active detection for the mutated VHL gene. The todays requirement should be the gene analysis of the VHL gene which distinguishes the VHL from sporadic HB from the very beginning. Close life-long observation of VHL patients is needed to recognize the eventual carcinoma soon. |